Efficacy and Safety of TACE Combined with Lenvatinib and PD-(L)1 Inhibitor in the Treatment of Unresectable Hepatocellular Carcinoma: A Retrospective Study

Yang H, Yang T, Qiu G, Liu J

Journal of Hepatocellular Carcinoma 2023, 10:1435-1443

Published Date: 5 September 2023